iifl-logo-icon 1

Amrutanjan Health Care Ltd Share Price

744.4
(-1.06%)
Jul 15, 2024|03:32:41 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open752.4
  • Day's High752.9
  • 52 Wk High825.15
  • Prev. Close752.4
  • Day's Low737
  • 52 Wk Low563.9
  • Turnover (lac)171.18
  • P/E48.31
  • Face Value1
  • Book Value116.12
  • EPS15.56
  • Mkt. Cap (Cr.)2,152.11
  • Div. Yield0.48
No Records Found

Amrutanjan Health Care Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

752.4

Prev. Close

752.4

Turnover(Lac.)

171.18

Day's High

752.9

Day's Low

737

52 Week's High

825.15

52 Week's Low

563.9

Book Value

116.12

Face Value

1

Mkt Cap (₹ Cr.)

2,152.11

P/E

48.31

EPS

15.56

Divi. Yield

0.48

Amrutanjan Health Care Ltd Corporate Action

9 Feb 2024

12:00 AM

Dividend

Dividend Amount: 1

Record Date: 20 Feb, 2024

arrow

2 Aug 2023

12:00 AM

BookCloser

arrow

14 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

2 Aug 2023

12:00 AM

AGM

Announcement Date: 02 Aug, 2023

arrow

Amrutanjan Health Care Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Amrutanjan Health Care Ltd SHAREHOLDING SNAPSHOT

15 Jul, 2024|02:26 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 50.58%

Foreign: 0.00%

Indian: 50.58%

Non-Promoter- 8.66%

Institutions: 8.66%

Non-Institutions: 40.67%

Custodian: 0.06%

Share Price

Amrutanjan Health Care Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

2.92

2.92

2.92

2.92

Preference Capital

0

0

0

0

Reserves

287.85

262.2

212.64

156.5

Net Worth

290.77

265.12

215.56

159.42

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

332.84

261.47

223.17

206.88

yoy growth (%)

27.29

17.16

7.87

12.2

Raw materials

-140.18

-117.07

-95.63

-83.37

As % of sales

42.11

44.77

42.84

40.29

Employee costs

-41.7

-39.36

-33.85

-29.67

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

81.9

34.45

31.08

35.09

Depreciation

-3.66

-4.35

-2.9

-2.04

Tax paid

-20.71

-9.37

-12.9

-11.98

Working capital

78.27

-1.63

12.83

6.67

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

27.29

17.16

7.87

12.2

Op profit growth

143.39

8.16

-5.46

-4.82

EBIT growth

137.64

11.08

-11.4

1.35

Net profit growth

143.94

25.58

-8.37

-2.76

View Ratios
Particulars (Rupees in Crores.)Mar-2017Mar-2016Mar-2015Mar-2014Mar-2013

Gross Sales

231.7

194.52

174.1

147.46

144.07

Excise Duty

10.61

9.05

8.32

7.05

7.4

Net Sales

221.1

185.47

165.78

140.41

136.66

Other Operating Income

2.88

1.28

0.79

1.32

0.99

Other Income

7.52

5.68

4.53

2.94

4.26

Amrutanjan Health Care Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,577.3

124.083,78,675.04867.60.865,536.9998.75

Cipla Ltd

CIPLA

1,512.05

32.871,22,092.681,038.40.563,444.92346.41

Divis Laboratories Ltd

DIVISLAB

4,539.3

76.441,20,480.265310.662,259507.93

Zydus Lifesciences Ltd

ZYDUSLIFE

1,175.15

34.281,18,217.41,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,719.45

26.171,12,137.091,034.80.595,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Amrutanjan Health Care Ltd

Management

Register Office

Registrar Office

CMD & Executive Director

S Sambhuprasad

Independent Non Exe. Director

Marie Shiranee Pereira

Independent Non Exe. Director

V Raja

Independent Non Exe. Director

Muralidharan Swayambunathan

Independent Non Exe. Director

Meena Lochani Raghunathan

Non Executive Director

Ramaa Prabhakar Arikirevula

Company Sec. & Compli. Officer

M Srinivasan.

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Amrutanjan Health Care Limited (AHCL) was incorporated on September 9, 1936 in Chennai, Tamil Nadu. The Chennai-based Amrutanjan manufactures bulk drugs and drug intermediates like theophylline, based on in-house research. Three plants have been set up in the Alandur industrial belt near Chennai to produce these products. It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore. Pheromones have found wide application as pesticides and are used on cotton crops. The Company is engaged into manufacture, supply, sale of products in pain management, congestion management, beverages & hygiene and services in pain management.Amrutanjan has an agreement with a company in Philadelphia, US, to supply custom-made chemicals for exotic applications like the genetic manipulation of biological matter. It has introduced some new range of products like Pep Pill, Amrutanjan gripe water sans alcohol, Amrutanjan Maha Strong, etc. Plans are afoot to introduce analgesic and antipyretic tablets. The company also plans to launch sanitary napkins soon. The company has approached the US FDA for approval and clearance to sell its new drugs in US. During 1996-97, it has introduced a new product called Cold Snap Gel and also a mint called tingle. Company having two subsidiary companies viz. Amrutanjan Drugs & Chemicals Ltd having holding stake 99.80% & Amrutanjan Finance Ltd, having holding stake is 57.26%.Company has take
Read More

Company FAQs

What is the Amrutanjan Health Care Ltd share price today?

Down Arrow

The Amrutanjan Health Care Ltd shares price on N/A is Rs.₹743.15 today.

What is the Market Cap of Amrutanjan Health Care Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Amrutanjan Health Care Ltd is ₹2148.49 Cr. as of 15 Jul ‘24

What is the PE and PB ratio of Amrutanjan Health Care Ltd?

Down Arrow

The PE and PB ratios of Amrutanjan Health Care Ltd is 48.31 and 7.53 as of 15 Jul ‘24

What is the 52 Week High and Low of Amrutanjan Health Care Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Amrutanjan Health Care Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Amrutanjan Health Care Ltd is ₹556.05 and ₹826 as of 15 Jul ‘24

What is the CAGR of Amrutanjan Health Care Ltd?

Down Arrow

Amrutanjan Health Care Ltd's CAGR for 5 Years at 19.50%, 3 Years at 1.47%, 1 Year at 2.66%, 6 Month at 27.90%, 3 Month at 15.80% and 1 Month at -0.07%.

What is the shareholding pattern of Amrutanjan Health Care Ltd?

Down Arrow

The shareholding pattern of Amrutanjan Health Care Ltd is as follows:
Promoters - 50.59 %
Institutions - 8.67 %
Public - 40.68 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.